Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE +13.17% Days Payable is 286.07 as of Apr. 2026, which is 24% above its 10-year median of 230.75. The stock has 5 warning signs investors should review. Among 1,891 Consumer Packaged Goods companies, PURE Bioscience ranks better than 96.83% on this metric.
The historical rank and industry rank for PURE Bioscience's Days Payable or its related term are showing as below:
PURE'
s Days Payable Range Over the Past 10 Years
Min: 119.55 Med: 230.75 Max: 429.97
Current: 289.07
During the past 13 years, PURE Bioscience's highest Days Payable was 429.97. The lowest was 119.55. And the median was 230.75.
PURE's Days Payable is ranked better than 96.83% of 1891
companies
in the Consumer Packaged Goods industry
Industry Median: 44.15
vs PURE: 289.07
PURE Bioscience's Days Payable
declined
from Apr. 2025 (328.81) to Apr. 2026 (286.07).
It may suggest that PURE Bioscienceaccelerated paying its suppliers.
PURE Bioscience Days Payable Related Terms
PURE Bioscience Days Payable Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, PURE Bioscience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PURE Bioscience Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's Days Payable distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PURE Bioscience's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE Bioscience (PURE) has a Days Payable of 286.07 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PURE Bioscience and its competitors. This is 24% above median its historical median of 230.75. Over the past decade, PURE Bioscience's Days Payable has ranged from 119.55 to 429.97. According to the industry distribution chart, PURE Bioscience ranks #60 out of 1891 companies in the Consumer Packaged Goods industry, placing it in the top 3.2%.
Is PURE Bioscience's Days Payable too high?
PURE Bioscience's current Days Payable of 286.07 is 24% above median its 10-year median of 230.75. Over the past 10 years, this metric has ranged from a low of 119.55 to a high of 429.97. The Consumer Packaged Goods industry median Days Payable is 44.15. PURE Bioscience's value of 286.07 is 548% above this industry median. Based on the distribution chart, PURE Bioscience ranks #60 out of 1891 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers.
How does PURE Bioscience's Days Payable compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #60 out of 1891 companies for Days Payable. This places PURE Bioscience in the top 3% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.15. PURE Bioscience's value of 286.07 is 548% above this benchmark. Historically, PURE Bioscience's own Days Payable has ranged from 119.55 to 429.97 over the past decade. While the company's 10-year median is 230.75 vs. the industry median of 44.15, PURE Bioscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.15, based on 1,891 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PURE Bioscience's current Days Payable of 286.07 is 548% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current Days Payable is 286.07, which is 24% above median its own 10-year median of 230.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current Days Payable is 286.07, which is 24% above median its 10-year median of 230.75 and 548% above the Consumer Packaged Goods industry median of 44.15. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PURE Bioscience (PURE), the current Days Payable is 286.07 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
